Vice President, Immunology and Rare Disease
Sheri Mullen is Vice President, Immunology and Rare Disease. Sheri has led GSK’s Immunology and Rare Disease business in the US since 2010 when she was appointed to build this new specialty business.
Sheri has 25 years of commercial experience. She joined GSK in 1990 as a sales representative and held various positions of increasing responsibility in Sales, Marketing, and Operations. Prior to heading the Immunology and Rare Disease team, Sheri was the Vice President of Sales for Oncology.
Find out more about our CEO and Board of Directors
Board of Directors
The Board of Directors is responsible for the group's system of corporate governance and is ultimately accountable for the group's activities, strategy, risk management and financial performance.
Find out more
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
GSK in the US
GSK is dedicated to helping grow the US economy and supporting communities by creating high-quality jobs in areas like R&D, manufacturing, and sales.
Our Pharmaceuticals business is made up of innovative and established medicines and holds leading market positions in respiratory disease and HIV.
Our Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. We deliver over two million vaccine doses per day to people living in over 160 countries.